News for MedTech Acquisition Corporation (MTAC)

SPAC Swiftmerge Acquisition Corp. (IVCP) has agreed to merge with with HDL Therapeutics through a deal that estimates the enterprise value at around $480M. Read more here.

MedTech Acquisition Corp. (MTAC) shareholders have voted in favor of the SPAC's planned merger with oncology products developer TriSalus Life Sciences. Read more here.

The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.10 A.M. ET)..

Waltham, MA, April 28, 2023 (GLOBE NEWSWIRE) --  LAVA Medtech Acquisition Corp. (NASDAQ: LVAC) (the “Company”) announced today that the board of...

TriSalus Life Sciences® Inc., an oncology company in the process of going public through a business combination transaction with MedTech Acquisition Corporation , today announced new Phase 1... | April 20, 2023

The Company recommends all of its stockholders to vote FOR the Extension Amendment at the upcoming Special Meeting. New York, NY, Dec. 07, 2022 ...

List of Participants · Chris Dewey, Chief Executive Officer, MedTech Acquisition Corporation ... | November 14, 2022

SPAC MedTech Acquisition (MTAC) has agreed to take a privately held oncology therapeutics company, TriSalus Life Sciences, public in a reverse merger deal valued at $244.4M.TriSalus...

Read Gilder Gagnon Howe & Co. LLC Has $8.35 Million Holdings in MedTech Acquisition Co. (NASDAQ:MTAC) at ETF Daily News